GKN2 and gastric carcinoma: We first comprehensively validated clinic‐pathological features of GKN2 expression in an independent cohort of 104 patients who underwent gastric carcinoma resection in the Fujian Provincial Cancer Hospital (Fujian cohort; see Patients and Specimens in Materials and Methods, Supporting Material 1).